Launching a drug development company with novel technology from academia
Our corporate group has worked with hundreds of entrepreneurs at this stage to help them optimally and efficiently select and form the appropriate legal entity
On October 11th, Faber Principal, Jill Alvarez, and Counsel, Heather Centauro, participated in a discussion on diversity in clinical trials, and the implications of the new federal guidelines (“FDORA”). Alvarez and Centauro were joined by Deborah Livornese, from Hyman, Phelps & McNamara, PC, and Helen Hemley from MGH Community Access. To view a recording of this webinar, please refer to the video below.
To watch in full screen, please double click the video.